Company news

PYC Therapeutics Limited news in 2026

PYC Therapeutics Limited's news releases, calls and decks from 2026, newest first.

View company

Change of Director's Interest Notice

November 5, 2026

Annual General Meeting - Conference Link

November 4, 2026

Change of Director's Interest Notice

November 3, 2026

Change of Director's Interest Notice

October 30, 2026

Exercise of Options and Cleansing Notice

October 29, 2026

Application for quotation of securities - PYC

October 29, 2026

Quarterly Activities/Appendix 4C Cash Flow Report

October 28, 2026

Quarterly Activities/Appendix 4C Cash Flow Report

October 28, 2026

PKD Program - ASN Presentation

October 22, 2026

Exercise of Options and Cleansing Notice

October 15, 2026

Notice of Annual General Meeting/Proxy Form

October 11, 2026

Application for quotation of securities - PYC

October 7, 2026

Notification of cessation of securities - PYC

October 7, 2026

PKD Program - Presentation of Data at ASN Conference

October 6, 2026

RP11 program - presentation at euretina 2026

October 1, 2026

PKD - First Patient Dosed in OLE Study

September 10, 2026

S&P DJI Announces September 2026 Quarterly Rebalance

September 4, 2026

Investor Webinar Presentation Q3 2026

September 3, 2026

ADOA Program - Data Presentation

September 2, 2026

Ceasing to be a substantial holder

September 2, 2026

PKD - Presentation of Clinical Safety Data

August 30, 2026

2026 Corporate Governance Statement

August 28, 2026

Appendix 4G

August 28, 2026

2026 Annual Report to Shareholders

August 28, 2026

Appendix 4E

August 28, 2026

Notification regarding unquoted securities - PYC

August 26, 2026

Investor Webinar

August 17, 2026

Change of Director's Interest Notice

August 13, 2026

Notification regarding unquoted securities - PYC

August 13, 2026

Quarterly Activities/Appendix 4C Cash Flow Report

July 28, 2026

PKD - Safety Committee Approves Dose Escalation

July 21, 2026

ADOA Program Update

July 20, 2026

PKD - Initiation of Multiple Dose Clinical Trial

May 6, 2026

Presentation of Ophthalmology Clinical Trial Data at ARVO

May 3, 2026

ADOA Program - SRC Approve Progression to Multi-Dose Study

April 15, 2026

Completion of Retail Entitlement Offer

March 3, 2026

PKD Clinical Trial - Approval to Escalate Dosing

February 26, 2026

Half Yearly Report and Accounts

February 23, 2026

Retail Offer Booklet

February 8, 2026

Completion of Placement and Institutional Entitlement Offer

February 3, 2026

PYC Raising up to $653m to Deliver Human Efficacy Data

February 1, 2026

PYC Capital Raising Presentation

February 1, 2026

Trading Halt

February 1, 2026

Quarterly Activities/Appendix 4C Cash Flow Report

January 22, 2026

Decks in 2026